Product HighlightsAn overview of the main features of med111
Available in Eight Languages
Our leaflets are available in English, German, French, Italian Spanish, Portuguese, Turkish, and Albanian
Leaflets are written in plain language so that all patients understand as much as possible. Technical jargon is avoided where possible.
Only the Most Important Info
A Take-Away for the Patients
The med111 leaflets can be accessed, printed and handed out very quickly.
No Conflict of Interest
This med111 service contains no advertising or sponsoring. It will be funded through its subscriptions.
The med111 leaflets represent a complement to a physician's consultation and the package inserts
Over 230 Drugs
This covers over 80% of the medications that a general practitioner prescribes
An Established Provider
We are planning to add extra languages both for the leaflets and the user interface. Additional drugs and additional output media are also in the works.
Product SpecificationsRead more on how med111 makes a difference
- Easy and Simple
- Almost 90% Coverage
- Only the Important Information
- Simple Language
- A Wide Range of Languages
- Independent and No Conflicts of Interest
Easy and Simple
Almost 90% Coverage
Only the Important Information
You don't want your patients to forget or miss what is most important by overloading them with too much information orally. Each med111 leaflet contains exactly the information that must be remembered. You can therefore concentrate on the most critical aspects during your conversation with the patient and then hand them an infosheet as a reference to be looked at later.
A Wide Range of Languages
The average health professional interacts with people who speak a different mother tongue and therefore have trouble communicating on a daily basis. We therefore made our leaflets available in eight languages: English, German, French, Italian, Spanish, Portuguese, Turkish, and Albanian. This means that almost everyone in Switzerland can get their med111 drug leaflet in their native language.
Independent and No Conflicts of Interest
Med111 is a service offered by the Swiss company Infomed-Verlags-AG. This publishing company has been publishing the pharma-kritik drug bulletin for almost 40 years. Infomed is a not for profit organization. None of its publications have any advertising or are sponsored. The same is true for the med111 information leaflets; the motivation for infomed is exclusively to help patients. You can feel assured that the information you hand to your patients is properly vetted and thoroughly reviewed.